Citations 2

Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer

New England Journal of Medicine | February 5, 2025 | Volume: 392 | Issue: 6 | Pages: 566-576

10.1056/nejmoa2405008 | PMID 39908431

Iberdomide (CC-220) Monotherapy or in Combination with an Anti-CD20 Monoclonal Antibody As Effective Therapy in Patients with Relapsed/Refractory Lymphoma: Early Results from a Phase 1/2 Study

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 569-572

10.1182/blood-2022-162559